Axcelis Technologies Inc
NASDAQ:ACLS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
| US |
|
Chevron Corp
NYSE:CVX
|
Energy
|
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
42.42
100.44
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Walmart Inc
NYSE:WMT
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
This alert will be permanently deleted.
Axcelis Technologies Inc
Axcelis Technologies Inc., a dynamic player in the semiconductor equipment industry, has carved its niche with a focus on ion implantation systems, an essential component in the fabrication of semiconductor chips. Picture a bustling factory floor, where intricate machines whir with precision; this is the heart of Axcelis's operations. The company designs and manufactures these high-tech systems that are crucial in controlling the electrical characteristics of silicon wafers. Through a process involving the acceleration and embedding of ions into the silicon lattice, Axcelis's technology plays a critical role in determining the speed, power consumption, and efficiency of electronic devices. This specialization has allowed the company to establish itself as a backbone in the semiconductor supply chain, supporting industries from consumer electronics to automotive manufacturing.
Revenue for Axcelis is primarily derived from the sale of these ion implantation systems and the accompanying extensive aftermarket services. Imagine a meticulous caretaker, ensuring that each machine it has placed in the vast network of global factories runs seamlessly. The company not only provides initial installations but also offers maintenance, spare parts, and system upgrades—integral components that ensure the prolonged lifecycle and enhanced performance of its equipment. As the semiconductor industry continues to experience rapid evolution, driven by the increasing demand for more powerful and efficient chips, Axcelis finds itself in a favorable position. By continually investing in research and development, the company aims to adapt its technology to the ever-changing needs of chip manufacturers, securing its place in the competitive landscape.
Axcelis Technologies Inc., a dynamic player in the semiconductor equipment industry, has carved its niche with a focus on ion implantation systems, an essential component in the fabrication of semiconductor chips. Picture a bustling factory floor, where intricate machines whir with precision; this is the heart of Axcelis's operations. The company designs and manufactures these high-tech systems that are crucial in controlling the electrical characteristics of silicon wafers. Through a process involving the acceleration and embedding of ions into the silicon lattice, Axcelis's technology plays a critical role in determining the speed, power consumption, and efficiency of electronic devices. This specialization has allowed the company to establish itself as a backbone in the semiconductor supply chain, supporting industries from consumer electronics to automotive manufacturing.
Revenue for Axcelis is primarily derived from the sale of these ion implantation systems and the accompanying extensive aftermarket services. Imagine a meticulous caretaker, ensuring that each machine it has placed in the vast network of global factories runs seamlessly. The company not only provides initial installations but also offers maintenance, spare parts, and system upgrades—integral components that ensure the prolonged lifecycle and enhanced performance of its equipment. As the semiconductor industry continues to experience rapid evolution, driven by the increasing demand for more powerful and efficient chips, Axcelis finds itself in a favorable position. By continually investing in research and development, the company aims to adapt its technology to the ever-changing needs of chip manufacturers, securing its place in the competitive landscape.
Revenue Beat: Axcelis reported Q3 revenue of $214 million, exceeding its outlook.
Profitability: Non-GAAP diluted EPS was $1.21, above the expected $1.00, driven by higher revenue and lower operating expenses.
CS&I Growth: Aftermarket (CS&I) revenue hit a record $70 million, up 9% year-over-year for the first nine months.
Bookings Down: Q3 bookings declined sequentially, mainly due to softer power and general mature segments, but are expected to improve in Q4.
Merger Update: Management highlighted the pending merger with Veeco, emphasizing cross-sell and technology synergies and a stronger market position.
China Exposure: Sales to China fell to 46% of total revenue, down from 55% in Q2, and are anticipated to decline again in Q4.
Q4 Guidance: Revenue expected at $215 million, with gross margin rebounding to 43% and non-GAAP EPS around $1.12.
Sector Trends: Management sees memory as a bright spot for 2026, while silicon carbide demand remains healthy but will fluctuate.